Pne01
Nov 19, 7:17 AM
$CRBP
RA capital bought 9,9% of Corbus AFTER the obesity readout 14 sept.
MPM BioImpact bought more and reported a 8,6% position AFTER the obesity readout 14 sept.
Does this mean they love CRB-913? Maybe not, rather they are in it for CRB-701. They both have an avarage buying price above 7$. No matter how the obesity asset plays out, these two firms belive Corbus is worth way more then 7$. Now we trade under 3$. 2027 will be a great year I'm certain.
0 replies